FOX
51
-6
BXP
49
-3
DLTR
38
-4
TSCO
44
-4
COP
57
-2
MUR
44
-3
PLD
45
-5
HAS
30
-2
XOM
42
-6
TXT
53
-3
OXY
36
-2
KLAC
38
-6
CMS
60
2
PYPL
52
-2
TXN
43
-5
HIG
66
2
KIM
72
2
GLW
45
-3
DOV
65
-4
F
56
-3
FOX
51
-6
BXP
49
-3
DLTR
38
-4
TSCO
44
-4
COP
57
-2
MUR
44
-3
PLD
45
-5
HAS
30
-2
XOM
42
-6
TXT
53
-3
OXY
36
-2
KLAC
38
-6
CMS
60
2
PYPL
52
-2
TXN
43
-5
HIG
66
2
KIM
72
2
GLW
45
-3
DOV
65
-4
F
56
-3
Financhill
Back

Appili Therapeutics 10K Form

Sell
29

APLIF
Appili Therapeutics

Last Price:
0.02
Seasonality Move:
-9.36%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive APLIF News And Ratings

See the #1 stock for the next 7 days that we like better than APLIF

APLIF Financial Statistics

Sales & Book Value

Annual Sales: $613.27K
Cash Flow: $-96.5K
Price / Cash Flow: 0
Annual Sales: $-0.07
Price / Book: 0

Profitability

EPS (TTM): -0.02310
Net Income (TTM): $-2.82M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Appili Therapeutics Earnings Forecast

Key Appili Therapeutics Financial Ratios

  • The Research & Development expenses have been 704.67% of Revenue.
  • The Interest Expense is -43.14% of Operating Income.
  • The Net Earning history of APLIF is -456.96% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 2 years.

Appili Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: APLIF
Website: appilitherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

APLIF Technical Analysis vs Fundamental Analysis

Sell
29
Appili Therapeutics (APLIF) is a Sell

Is Appili Therapeutics a Buy or a Sell?